1. Home
  2. CHR vs HCWB Comparison

CHR vs HCWB Comparison

Compare CHR & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheer Holding Inc.

CHR

Cheer Holding Inc.

N/A

Current Price

$1.36

Market Cap

3.6M

Sector

Technology

ML Signal

N/A

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

N/A

Current Price

$1.10

Market Cap

3.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHR
HCWB
Founded
2016
2018
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
3.6M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
CHR
HCWB
Price
$1.36
$1.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
85.4K
★ 86.0K
Earning Date
07-28-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.06
N/A
Revenue
N/A
★ $4,099,750.00
Revenue This Year
$105.44
$12,215.61
Revenue Next Year
$30.02
N/A
P/E Ratio
$22.87
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.03
$0.86
52 Week High
$2.95
$23.94

Technical Indicators

Market Signals
Indicator
CHR
HCWB
Relative Strength Index (RSI) 44.14 32.80
Support Level $0.73 $1.12
Resistance Level $1.69 $1.73
Average True Range (ATR) 0.13 0.09
MACD -0.00 0.04
Stochastic Oscillator 33.78 13.89

Price Performance

Historical Comparison
CHR
HCWB

About CHR Cheer Holding Inc.

Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Share on Social Networks: